Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glass House BrandsGLAS -5.62%65 Days Sales Outstanding is 92.28 as of Jun. 2026, which is 622% above its 10-year median of 12.78. GuruFocus rates GLAS with a GF Score™ of 65/100 and a GF Value™ of $5.12 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 947 Drug Manufacturers companies, Glass House Brands ranks better than 96.94% on this metric.
Glass House Brands (NYSE:GLAS) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Glass House Brands Days Sales Outstanding Related Terms
Glass House Brands Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Glass House Brands's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Glass House Brands's Days Sales Outstanding falls into.
Glass House Brands Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glass House Brands (GLAS) has a Days Sales Outstanding of 92.28 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Glass House Brands and its competitors. This is 622% above median its historical median of 12.78. Over the past decade, Glass House Brands' Days Sales Outstanding has ranged from 8.36 to 38.88. According to the industry distribution chart, Glass House Brands ranks #29 out of 947 companies in the Drug Manufacturers industry, placing it in the top 3.1%.
Is Glass House Brands' Days Sales Outstanding too high?
Glass House Brands' current Days Sales Outstanding of 92.28 is 622% above median its 10-year median of 12.78. Over the past 10 years, this metric has ranged from a low of 8.36 to a high of 38.88. The Drug Manufacturers industry median Days Sales Outstanding is 71.98. Glass House Brands' value of 92.28 is 28.2% above this industry median. Based on the distribution chart, Glass House Brands ranks #29 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Glass House Brands has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #29 out of 947 companies for Days Sales Outstanding. This places Glass House Brands in the top 3% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 71.98. Glass House Brands' value of 92.28 is 28.2% above this benchmark. Historically, Glass House Brands' own Days Sales Outstanding has ranged from 8.36 to 38.88 over the past decade. While the company's 10-year median is 12.78 vs. the industry median of 71.98, Glass House Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.98, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Days Sales Outstanding of 92.28 is 28.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Days Sales Outstanding is 92.28, which is 622% above median its own 10-year median of 12.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.12, compared to a current price of $9.41 — trading 83.8% above its estimated fair value. The current Days Sales Outstanding is 92.28, which is 622% above median its 10-year median of 12.78 and 28.2% above the Drug Manufacturers industry median of 71.98. Glass House Brands' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Glass House Brands (GLAS), the current Days Sales Outstanding is 92.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLAS) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $9.41 is trading 83.8% above its estimated GF Value™ of $5.12.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLAS:
Days Sales Outstanding: 92.28 (622% above median its 10-year median of 12.78)
GF Value™: $5.12 vs. price of $9.41 (83.8% above fair value)
Industry Position: 28.2% above the Drug Manufacturers median (#29 of 947)
No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
65GF Score
Get the complete analysis for GLAS
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAS has been successfully added to your 
